Disease spotlight: Duchenne muscular dystrophy (DMD)
Views & Analysis
News
Pulmonary fibrosis drug developer Avalyn files IPO
Avalyn Pharma hops on the IPO train, filing to list on the Nasdaq and raise funds for late-stage trials of its inhaled pulmonary fibrosis therapies.
Sales & Marketing
Sponsored
Using AI-driven synthetic personas to take your insights fur...
As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
Market Access
12 questions with: Daniel Kohlstaedt
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
R&D
Sponsored
A data-driven guide to small molecule drug discovery and dev...
A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.
Oncology
LSX2026: Addressing adult eye cancer, with Roi Raz
Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Digital
Sponsored
Expert Directed Applied Intelligence: Redefining AI in Life ...
In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
R&D
Partner Content
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
Category :
Views & Analysis
/